Article Text

PDF

The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.
  1. D A Evans,
  2. D Harmer,
  3. D Y Downham,
  4. E J Whibley,
  5. J R Idle,
  6. J Ritchie,
  7. R L Smith

    Abstract

    Debrisoquine and sparteine tests were carried out in 215 random white British subjects. There is a high degree of correlation between the urinary 'metabolic ratios' of the two drugs. New mathematical techniques have been developed (1) to define phenotypes and (2) to identify the genotypes within the dominant phenotype. The members of 15 families were tested with both debrisoquine and sparteine. The results indicate that persons who are 'poor metabolisers' of sparteine are also 'poor metabolisers' of debrisoquine and are autosomal Mendelian recessives.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.